ARRY - serious question...
I don't follow ARRY closely, so forgive if this comes off as glib. But is there differentiation among the three MEK inhibitors? Shouldn't one be their best shot at this target?
I am reminded of teams that have three quarterbacks or three closers - which of course means they, in fact, have none.
Any comments here may have previously been disseminated on Twitter @BioDueDiligence or at www.biotechduediligence.com